) 400.00% (0.85%) 0.18% Finance costs (37.20 ) (42.77 ) (5.57 ) 13.02% (26.47%) (19.55%) Tax income (expense) - - N/A N/A 0.00% N/A Profit (loss) for the period (59.89 ) (169.04 ) 109.15 64.57% (42.62
%) 0.18% Finance costs (37.20 ) (42.77 ) (5.57 ) 13.02% (26.47%) (19.55%) Tax income (expense) - - N/A N/A 0.00% N/A Profit (loss) for the period (59.89 ) (169.04 ) 109.15 64.57% (42.62%) (77.27%) Profit
which is accounted to 0.188% of NTA as September 30, 2019. 3.1.2 Share MIS (Management Information System) resource transaction 1. Contract Date: July 1, 2019 - June 30, 2020 2. Partners of Contract
) (37.20 ) (0.71 ) 1.91% (23.73%) (26.47%) Tax income (expense) (3.15 ) 0.00 (3.15 ) N/A (1.97%) 0.00% Profit (loss) for the period (84.18 ) (59.89 ) (24.29 ) (40.56%) (52.68%) (42.62%) Basic earnings per
measurements directly affect with the business of Wuttisak Clinic Intergroup Co., Ltd. (“Wuttisak Clinic” or “WCIG” indirect subsidiary, hold share by WCI Holding PCL) to close all branches resulting in lack of
Financial expenses 1.76 0.30% 1.60 0.33% 0.16 9.98 Share of losses from associates 0.17 0.03% 0 0% 0.17 100 Income tax 8.12 1.37% 6.92 1.42% 1.21 17.44 Net profit 21.14 3.58% 37.03 7.61% (15.89) (42.92
(24,987) (102.3) Total comprehensive income attributable to: Equity holders of the Bank 1,795,576 1,660,974 134,602 8.1 Non-controlling interests (1,121) 22,037 (23,158) (105.1) Earnings per share of Equity
marketing strategy, OSP market share was maintained at 53.5%, aligned with our mid-term guidance. In Functional drinks market, C-Vitt, now a No.1 brand, strongly drove the market to grow by 19.3% YoY. At the